It is important to mention that BARHL2 has been found aberrantly methylated in epithelial and hematological tumours as well as brain tumours [62–66] and its putative role as tumour suppressor has been suggested in gastric cancer [65]. Here, BARHL2 is linked to brain neoplasm.